Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2013


Clinical Trials in CNS

18 Nov 2013 - 19 Nov 2013 - London, UK



Bookmark and Share


SMi is proud to present the 12th Annual...

Clinical Trials in CNS

The highly anticipated and respected 12th annual Clinical Trials in CNS Conference returns to London with a two day content packed agenda featuring new approaches taken in this field towards a number of neurodegenerative disorders, from clinical trial modelling and simulation to the role of biomarkers, the agenda presents a detailed look into many aspects of drug discovery and delivery of CNS therapeutics. This innovative conference will give delegates an opportunity to gain insights through case studies and interactive discussion into the best practices in clinical trials. 

>>>>>Event highlights include:

Learn the importance of understanding the pathophysiology and biology of disease processes with use of biomarkers and imaging techniques

Discover ways to design late stage clinical trials

Overcome challenges of delivery within the CNS

Determine the legal and ethical issues behind sham surgery

KEYNOTE SPEAKERS INCLUDE:

Larry Alphs, Therapeutic Area Leader, Johnson & Johnson

Lars Bauer, Senior Medical Director TA CNS, UCB Pharma

Tom Isaacs, Co-founder, Cure Parkinson’s Trust

Kyriacos Mitrophanous, Head of Research, Oxford Biomedica

Mathieu Albasser, Post Doctoral Researcher, Eli Lilly 

Johannes Streffer, Senior Director, Experimental Medicine Europe, Janssen Research & Development

Warren Hirst, Associate Research Fellow Neurodegeneration Research, Pfizer

Eric Karran, Director of Research, Alzheimers Research UK

PLUS AN INTERACTIVE POST-CONFERENCE WORKSHOP

20TH NOVEMBER 2013 | MARRIOTT REGENTS PARK HOTEL | LONDON, UK

Defining Clinical Relevance

Workshop Leaders: Susan Mcgoldrick, Managing Director, QCTR

Audrey Jamieson, Business Development Manager, QCTR

08.30 - 12.30

**Book by 19th July 2013 and save £300**

**Book by 31st September 2013 and save £100**

Visit our website here: http://www.smi-online.co.uk/goto/clinicaltrialscns26.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk

Academic & Group discounts available




Further information
Scientific News
The Rise of 3D Cell Culture and in vitro Model Systems for Drug Discovery and Toxicology
An overview of the current technology and the challenges and benefits over 2D cell culture models plus some of the latest advances relating to human health research.
Grant Supports Project To Develop Simple Test To Screen For Cervical Cancer
UCLA Engineering announces funding from Bill and Melinda Gates Foundation.
Injecting New Life into Old Antibiotics
A new fully synthetic way to make a class of antibiotics called macrolides from simple building blocks is set to open up a new front in the fight against antimicrobial drug resistance.
Insight into Bacterial Resilience and Antibiotic Targets
Variant of CRISPR technology paired with computerized imaging reveals essential gene networks in bacteria.
Advancing Protein Visualization
Cryo-EM methods can determine structures of small proteins bound to potential drug candidates.
Alzheimer’s Protein Serves as Natural Antibiotic
Alzheimer's-associated amyloid plaques may be part of natural process to trap microbes, findings suggest new therapeutic strategies.
Slime Mold Reveals Clues to Immune Cells’ Directional Abilities
Study from UC San Diego identifies a protein involved in the directional ability of a slime mold.
How Do You Kill A Malaria Parasite?
Drexel University scientists have discovered an unusual mechanism for how two new antimalarial drugs operate: They give the parasite’s skin a boost in cholesterol, making it unable to traverse the narrow labyrinths of the human bloodstream. The drugs also seem to trick the parasite into reproducing prematurely.
Illuminating Hidden Gene Regulators
New super-resolution technique visualizes important role of short-lived enzyme clusters.
Supressing Intenstinal Analphylaxis in Peanut Allergy
Study from National Jewish Health shows that blockade of histamine receptors suppresses intestinal anaphylaxis in peanut allergy.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!